Reactive oxygen species and hypertension a complex association

Antioxidants and Redox Signaling

Volumn 10, Issue 6, 2008, Pages 1041-1044

  Touyz, Rhian M ^a   Schiffrin, Ernesto L ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN II; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

BIOAVAILABILITY; DOWN REGULATION; EDITORIAL; ENDOPLASMIC RETICULUM; HUMAN; HYPERTENSION; MACROPHAGE; MYOFILAMENT; NEUTROPHIL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

HUMANS; HYPERTENSION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 41349097493     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.2012     Document Type: Editorial

References (40)

1. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004.
2. Alom-Ruiz SP, Anilkumar N, and Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 10: 1089-1100.
3. Anderson GF and Chu E. Expanding priorities: confronting chronic disease in countries with low income. N Engl J Med 356: 209-211, 2007.
4. Delles C, Miller WH, and Dominiczak AF. Targeting reactive oxygen species in hypertension. Antioxid Redox Signal 10: 1061-1077.
5. Berndt C, Lillig CH, and Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 292: H1227-H1236, 2007.
6. Callera GE, Montezano AC, Yogi A, Tostes RC, He Y, Schiffrin EL, and Touyz RM. c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension 46: 1032-1038, 2005.
7. Callera GE, Tostes RC, Yogi A, Montezano AC, and Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci (Lond) 110: 243-253, 2006.
8. Czernichow S, Bertrais S, Blacher J, Galan P, Briançon S, Favier A, Safar M, and Hercberg S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens 23: 2013-2018, 2005.
9. Ebrahimian T and Touyz RM. Thioredoxin in vascular biology: role in hypertension. Antioxid Redox Signal 10: 1127-1136.
10. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19: 1807-1810, 2007.
11. Gill PS and Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607, 2006.
12. Gupte SA and Wolin MS. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid Redox Signal 10: 1137-1152.
13. Griendling KK. NADPH oxidases: new regulators of old functions. Antioxid Redox Signal 8: 1443-1445, 2006.
14. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962, 2002.
15. Hoshino Y, Shioji K, Nakamura H, Masutani H, and Yodoi J. From oxygen sensing to heart failure: role of thioredoxin. Antioxid Redox Signal 9: 689-699, 2007.
16. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 285: R277-R297, 2003.
17. Laurindo FRM, Fernandes DC, Amanso AM, Lopes LR, and Santos CXC. Novel role of protein disulfide isomerase in the regulation of NADPH oxidase activity: pathophysiological implications in vascular diseases. Antioxid Redox Signal 10: 1101-1113.
18. Martínez-Ruiz A and Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 75: 220-228, 2007.
19. Moens AL and Kass DA. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. J Cardiovasc Pharmacol 50: 238-246, 2007.
20. Nagai H, Noguchi T, Takeda K, Ichijo H. Pathophysiological roles of ASK1-MAP kinase signaling pathways. J Biochem Mol Biol 40: 1-6, 2007.
21. Papaharalambus CA and Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17: 48-54, 2007.
22. Paravicini TM and Touyz RM. Redox signaling in hypertension. Cardiovasc Res 71: 247-258, 2006.
23. Park JB and Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 19: 921-930, 2001.
24. Watson T, Goon PKY, and Lip GYH. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal 10: 1079-1088.
25. Parslow RA, Sachdev P, Salonikas C, Lux O, Jorm AF, and Naidoo D. Associations between plasma antioxidants and hypertension in a community-based sample of 415 Australians aged 60-64. J Hum Hypertens 19: 219-226, 2005.
26. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923, 1996.
27. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, and Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003.
28. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, and Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346, 2003.
29. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, and Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 255-260, 2007.
30. Romanowski A, Murray JR, and Huston MJ. Effects of hydrogen peroxide on normal and hypertensive rats. Pharm Acta Helv 35: 354-357, 1960.
31. Schulz E, Jansen T, Wenzel P, Daiber A, and Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115-1126.
32. Sugden PH and Clerk A. Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxid Redox Signal 8: 2111-2124, 2006.
33. Touyz RM and Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001.
34. Ungvari Z, Wolin MS, and Csiszar A. Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling? Antioxid Redox Signal 8: 1121-1129, 2006.
35. Virdis A, Neves MF, Amiri F, Touyz RM, and Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22: 535-542, 2004.
36. Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, and Croft KD. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic Biol Med 36: 226-232, 2004.
37. Wei Y, Whaley-Connell AT, Chen K, Habibi J, Uptergrove GM, Clark SE, Stump CS, Ferrario CM, and Sowers JR. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 50: 384-391, 2007.
38. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P, and Wilcox CS. Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 48: 934-941, 2006.
39. Williams HC and Griendling KK. NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol 50: 9-16, 2007.
40. Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano FJ, Shadel G, Sessa WC, and Min W. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol 170: 1108-1120, 2007.